AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 77 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,367,000 | +231.0% | 293,000 | +225.6% | 0.13% | +158.8% |
| Q1 2020 | $715,000 | -38.1% | 90,000 | -36.2% | 0.05% | -30.1% |
| Q4 2017 | $1,156,000 | -21.9% | 141,000 | 0.0% | 0.07% | -36.5% |
| Q3 2017 | $1,481,000 | -4.8% | 141,000 | 0.0% | 0.12% | -8.7% |
| Q2 2017 | $1,555,000 | +13.9% | 141,000 | 0.0% | 0.13% | +11.5% |
| Q1 2017 | $1,365,000 | – | 141,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 520,830 | $2,625,000 | 1.69% |
| COWEN AND COMPANY, LLC | 1,905,990 | $9,606,000 | 1.57% |
| Ghost Tree Capital, LLC | 825,000 | $4,158,000 | 1.20% |
| GENDELL JEFFREY L | 1,115,211 | $5,621,000 | 1.18% |
| Vivo Capital, LLC | 3,526,093 | $17,772,000 | 1.03% |
| ACUTA CAPITAL PARTNERS, LLC | 705,218 | $3,554,000 | 0.96% |
| RTW INVESTMENTS, LP | 5,366,705 | $27,048,000 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 2,840,669 | $14,317,000 | 0.50% |
| Avoro Capital Advisors LLC | 4,200,000 | $21,168,000 | 0.30% |
| HighVista Strategies LLC | 57,495 | $290,000 | 0.21% |